A Randomized Pilot Study of Donor Stem Cell Infusion in Living-Related Kidney Transplant Recipients Receiving Alemtuzumab

BACKGROUND: Transplant tolerance would remove the need for maintenance immunosuppression while improving survival and quality of life. METHODS: A prospective, randomized pilot study was undertaken to assess the safety and efficacy of donor stem cell infusion (DSCI) in living-related kidney transplan...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Ciancio, Gaetano, Sageshima, Junichiro, Akpinar, Edip, Gaynor, Jeffrey J, Chen, Linda, Zarak, Alberto, Hanson, Lois, Tueros, Lissett, Guerra, Giselle, Mattiazzi, Adela, Kupin, Warren, Roth, David, Ricordi, Camillo, Burke, George W
Format: Artigo
Langue:Inglês
Publié: 2013
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3818358/
https://ncbi.nlm.nih.gov/pubmed/23903014
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/TP.0b013e3182a0f68c
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires